Recommendations and outcomes from a geriatric assessment guided multidisciplinary clinic prior to autologous stem cell transplant in older patients

• Published in: Journal of geriatric oncology 2021-05, Vol.12 (4), p.585-591
• Main Authors: Derman, Benjamin A., Kordas, Keriann, Molloy, Emily, Chow, Selina, Dale, William, Jakubowiak, Andrzej J., Jasielec, Jagoda, Kline, Justin P., Kosuri, Satyajit, Lee, Sang Mee, Liu, Hongtao, Riedell, Peter A., Smith, Sonali M., Bishop, Michael R., Artz, Andrew S.
• Format: Article
• Language: English
• Subjects: Autologous; Geriatric assessment; Hematopoietic cell transplant; Older adults
• ISSN: 1879-4068; 1879-4076
• DOI: 10.1016/j.jgo.2020.10.019

Autologous hematopoietic stem cell transplant (autoHCT) is a mainstay of treatment for multiple myeloma and non-Hodgkin lymphoma but is underutilized in older adults. We investigated the association of vulnerabilities identified by a geriatric assessment (GA)-guided multidisciplinary clinic (MDC) on the receipt of autoHCT and evaluated its ability to predict outcomes in older autoHCT candidates. Patients 50+ years received GA-informed optimization recommendations: ‘decline’ if unlikely to realize benefits of autoHCT, ‘defer’ if optimization necessary before autoHCT, and ‘proceed’ if autoHCT could proceed without delay. We compared characteristics and outcomes of autoHCT recipients (n = 62) to non-autoHCT patients (n = 29) and evaluated GA deficits on outcomes. 91 patients were evaluated; the MDC recommendation was ‘decline’ for 5 (6%), ‘defer’ for 25 (27%), and ‘proceed’ for 61 (67%). AutoHCT recipients had fewer GA-rated impairments relative to non-autoHCT patients, as did patients with a ‘proceed’ recommendation relative to ‘defer’. Among autoHCT recipients, 1-year and 3-year non-relapse morality (NRM) was 0% and 5%, and there was no difference in length of hospitalization, readmission rate, or mortality after transplant by MDC recommendation. Frail grip strength and poor performance status were associated with inferior post-autoHCT progression-free survival and overall survival. Patients pursuing autoHCT after MDC-directed optimization achieved excellent outcomes, including patients deferred but ultimately receiving autoHCT. GA-identified functional deficits, especially frail grip strength, may improve risk stratification in older autoHCT candidates. Employing a GA earlier in the disease trajectory to inform early referral to an MDC may increase autoHCT safety and utilization in older patients.